Skip to content

Mindfulness-based cognitive therapy for youth with anxiety disorders at risk for bipolar disorder: a pilot trial.

Sian Cotton, Christina M. Luberto, Richard W. Sears, Jeffrey R. Strawn, Lauren A Stahl, Rachel S. Wasson, Thomas J. Blom, Melissa P. DelBello

Early Intervention in Psychiatry October 2016 DOI: 10.1111/eip.12216 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Uncontrolled pre-post pilot study Peer reviewed
Sample size 10
Population Youth (children and adolescents) with generalized, social and/or separation anxiety disorders who have a parent with bipolar disorder; mean age 13.2 years, 80% girls, 40% biracial
Intervention Mindfulness-based cognitive therapy for children (MBCT-C)
Duration 12 weekly sessions
Topics Anxiety Meditation
Keywords Mbct-c Bipolar Youth
Key points Clinician-rated anxiety decreased from a mean of 11.1 before to 4.3 after 12 weeks of MBCT-C, and youth-rated trait anxiety also decreased, with increases in mindfulness associated with decreases in anxiety. The authors report high feasibility, acceptability, and usefulness, and conclude that MBCT-C shows preliminary efficacy for anxiety in youth at risk for bipolar disorder, while noting that larger controlled studies are needed.

Abstract

Children and adolescents with bipolar parents have an elevated risk for anxiety disorders. However, antidepressant medications commonly used to treat symptoms of anxiety may accelerate the onset of mania in these already at-risk youth. Therefore, studies evaluating innovative non-pharmacologic treatments for anxiety in this population are urgently needed. Subjects participated in 12 weekly sessions of mindfulness-based cognitive therapy for children (MBCT-C), a manualized group psychotherapeutic intervention utilizing cognitive behavioural principles and mindfulness exercises to increase regulation of attention and non-judgmental acceptance of present moment thoughts, emotions and experiences. Independent raters administered symptoms rating scales prior to each treatment session. Spearman correlations and paired-samples signed rank tests were used to examine outcomes. After-intervention surveys and session transcripts were reviewed to assess feasibility and acceptability of the intervention. Participants included 10 youth (meanage = 13.2; 80% girls; 40% biracial) with generalized, social and/or separation anxiety disorders, and a parent with bipolar disorder. Clinician-rated anxiety was significantly reduced after intervention (meanbefore = 11.1; meanafter = 4.3; P < 0.01), as well as youth-rated trait anxiety (P = 0.03). Parent-rated emotion regulation significantly increased from before to after intervention (P = 0.05). Increases in mindfulness were associated with decreases in anxiety (P = 0.03). Finally, children and parents/guardians reported high levels of feasibility, acceptability and usefulness of the intervention. Findings support the feasibility, acceptability and preliminary efficacy of MBCT-C for treating anxiety in youth at risk for bipolar disorder. Future controlled and larger studies are needed to confirm these preliminary findings.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Citations in the library

Cited by 18

and 13 more in the library

Cites 16

and 11 more in the library

Explore topics